Scuola Superiore Meridionale, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, University of Naples Federico II, Gustave Roussy, University of Naples Federico II, Harvard University - Dana-Farber Cancer Institute, University of Naples Federico II, University of Naples Federico II, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, ASL Napoli 3 Sud, ASL Napoli 3 Sud, Università Vita-Salute San Raffaele - IRCCS Ospedale San Raffaele, University of Milan, University of Naples Federico II, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), IRCCS-Fondazione Bietti, University of Naples Federico II, Baylor College of Medicine and University of Naples Federico II

Istituto Oncologico Veneto – IRCCS, SOLTI Breast Cancer Research Group, European Institute of Oncology (IEO) IRCCS - Division of New Drugs and Early Drug Development for Innovative Therapies, IRCCS-Fondazione Bietti, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), University of Piemonte Orientale, Universidad Católica de Salta, - Hospital General Universitario Gregorio Marañón, IRCCS Ospedale Policlinico San Martino, Hospital Clinic of Barcelona - Department of Medical Oncology, Università degli Studi di Udine and Vall d’Hebron Institute of Oncology (VHIO)